CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart
about
CD36: implications in cardiovascular diseaseSoluble CD36 ectodomain binds negatively charged diacylglycerol ligands and acts as a co-receptor for TLR2.Synthetic Growth Hormone-Releasing Peptides (GHRPs): A Historical Appraisal of the Evidences Supporting Their Cytoprotective Effects.Platelet hyperreactivity, scavenger receptors and atherothrombosis.Modified peptide monolayer binding His-tagged biomolecules for small ligand screening with SPR biosensors.Integrating GHS into the Ghrelin System.The cardiovascular action of hexarelin.Regulation of platelet function by class B scavenger receptors in hyperlipidemiaPlatelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype.OxLDL or TLR2-induced cytokine response is enhanced by oxLDL-independent novel domain on mouse CD36Growth hormone secretagogues protect mouse cardiomyocytes from in vitro ischemia/reperfusion injury through regulation of intracellular calcium.Ghrelin: a link between eating disorders, obesity and reproduction.Salvianolic acid B inhibits macrophage uptake of modified low density lipoprotein (mLDL) in a scavenger receptor CD36-dependent manner.Ghrelin and GHS on cardiovascular applications/functions.Cell biology of the ghrelin receptor.Heterogeneity of ghrelin/growth hormone secretagogue receptors. Toward the understanding of the molecular identity of novel ghrelin/GHS receptors.Hexarelin Signaling to PPARgamma in Metabolic Diseases.The macrophage scavenger receptor at 30 years of age: current knowledge and future challenges.Peptide scanning for studying structure-activity relationships in drug discovery.Implications of ghrelin and hexarelin in diabetes and diabetes-associated heart diseases.Mapping and characterization of the binding site for specific oxidized phospholipids and oxidized low density lipoprotein of scavenger receptor CD36.Cardiomyocyte-specific ablation of CD36 accelerates the progression from compensated cardiac hypertrophy to heart failure.Ghrelin stimulates myogenic differentiation in a mouse muscle satellite cell line and in primary cultures of bovine myoblasts.CD36-mediated cholesterol efflux is associated with PPARgamma activation via a MAPK-dependent COX-2 pathway in macrophages.Fatty acid oxidation in cardiac and skeletal muscle mitochondria is unaffected by deletion of CD36.CD36 in chronic kidney disease: novel insights and therapeutic opportunities.Identification of the growth hormone-releasing peptide binding site in CD36: a photoaffinity cross-linking studyEffects of ghrelin upon gonadotropin-releasing hormone and gonadotropin secretion in adult female rats: in vivo and in vitro studies.Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT.Chronic administration of hexarelin attenuates cardiac fibrosis in the spontaneously hypertensive rat.Feeding behavior during long-term hexarelin administration in young and old rats.Cardiac-specific adipose triglyceride lipase overexpression protects from cardiac steatosis and dilated cardiomyopathy following diet-induced obesity.Prevention of export of anoxia/reoxygenation injury from ischemic to nonischemic cardiomyocytes via inhibition of endocytosis.Microdialysis SPR: diffusion-gated sensing in blood.Pharmacologic Reprogramming Designed to Induce a Warburg Effect in Porcine Fetal Fibroblasts Alters Gene Expression and Quantities of Metabolites from Conditioned Media Without Increased Cell Proliferation.Improvement of cardiomyocyte function by in vivo hexarelin treatment in streptozotocin-induced diabetic rats.Platelet glycoprotein IV (CD36) binds ligandsPlasma ghrelin concentrations are positively associated with carotid artery atherosclerosis in males.Hexarelin Modulates the Expression of Growth Hormone Secretagogue Receptor Type 1a mRNA at Hypothalamic and Pituitary SitesMonomeric C-reactive protein is prothrombotic and dissociates from circulating pentameric C-reactive protein on adhered activated platelets under flow.
P2860
Q24678338-6B97284A-9037-4EA9-8D2E-93F3044AF3C8Q33511748-4B06AF41-9A20-4570-BCDD-1C3E4A0554EFQ33565870-7E467BAF-97BB-4B59-A6F6-9B75DD3B0A38Q33801221-333D5B1E-D849-4873-90AC-171B2A7A9318Q33941335-11DC4991-BE7A-4DDD-AA63-90B7297E0902Q34078389-69F410E5-0B63-4967-A1CB-7A1B58A379A4Q34260468-82283B94-AFCD-4ABE-9A84-58D50D90119DQ34397435-775026C7-C7DF-4B21-A598-E59CDFA65230Q34592643-A4C1C157-427E-45FF-8065-5A42092DEC7FQ34803791-55F2D63F-D590-4316-90B1-D77CBE0E3310Q35874252-09BAD8C7-8866-45BA-B11D-4E57D16499B8Q36025681-4B6EFA49-290E-4F4A-B9C9-10E8A231A3E5Q36074293-30847B84-5B6B-4ABA-B15D-4AB80F902140Q36349408-E59554DA-0B4F-4DE4-B019-4AD5379ECE39Q36383869-F7BC47D7-7957-4C26-9682-69DC6B608DD5Q36876106-A5B80227-C1C5-465C-9F2A-4911BE1A9EE7Q37089762-73209008-FE5C-493A-8306-D456A3E74822Q37346790-4953F99E-49AF-43E7-84CA-C59074946476Q38068571-3F100DB0-CEE8-49C9-ACE0-6ACD4681919AQ38341934-39628A9C-D05A-4888-A74A-0EB77B9C213CQ38923555-EB231E56-B9AC-4EB7-8E13-A9DA4C49288AQ39035028-941D6334-93B4-4887-B861-7FBE8500956CQ39503244-9AAB054A-905A-4C8E-A8E3-4397E8831D84Q39859282-6C12C71B-0CC4-4FF7-9DF0-894DBFF2A5C9Q41831699-FBEC345F-9B87-4A7B-8CE4-1F3188D40ABAQ41935783-667A545E-953F-4592-9314-5DF27F6A9C7EQ42087576-DDA75A70-3DA7-4D4F-BB3E-BBFC8D48972CQ42495834-E7891CCC-86DE-4252-A6A1-6ACEFB01C94CQ42918384-C6BD623F-8E6E-4910-B77A-97F7D9B60F8FQ43658720-9A6F69A9-3030-4C09-ABAF-ADA1E753BE9FQ43660787-1B36B6FE-EDE7-4F29-8BBB-C0068BFC9BF8Q43821283-D5AB5193-0D58-46E1-A849-5ED59CAB86A3Q46900360-7055F115-E5FB-4E94-BA41-F0D6DFF5289EQ47160074-2FBF5D88-22FE-4F92-9239-73D04052FE53Q49259434-AB7FB7D5-25EC-4FFB-A3AF-6FC913CCC3C8Q49989710-DBF66164-7763-4873-A608-9842BC45A6FBQ50189578-B54FF7E4-B605-4137-99F1-81B76CDDEC50Q51496026-3D9F75D7-AFDF-44E4-9CE3-CD1023769B55Q54416724-82A5B5C7-B54A-4B62-95F8-9D47569B96FBQ54566349-5C08E6D0-5EC3-4684-B82C-5D3543AA4B08
P2860
CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart
description
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2002
@ast
im Mai 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2002/05/03)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd op 2002/05/03)
@nl
наукова стаття, опублікована в травні 2002
@uk
مقالة علمية (نشرت في 3-5-2002)
@ar
name
CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart
@ast
CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart
@en
CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart
@nl
type
label
CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart
@ast
CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart
@en
CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart
@nl
prefLabel
CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart
@ast
CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart
@en
CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart
@nl
P2093
P1433
P1476
CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart
@en
P2093
A. Perreault
D. Lamontagne
M. Febbraio
N. McNicoll
P. Pohankova
R. L. Silverstein
T. Sejlitz
P304
P356
10.1161/01.RES.0000016164.02525.B4
P577
2002-05-03T00:00:00Z